Fact CheckerSign in

NCT05384353CompletedPhase 1

In vivo PET of synaptic density in cognitive disorders: prospective evaluation of neuronal dysfunction and relation to symptomatology.

Source: EU CTIS (euclinicaltrials.eu) · Last updated 19 Jun 2024

Status (registry)
Completed
Phase (registry)
Phase 1
Study type
Interventional
Enrollment
150 (actual)
First submitted
12 Jun 2024
Start date
12 Jul 2024
Lead sponsor
UZ Leuven
NCT number
NCT05384353
EU CT number
2024-514577-22-00

What you commit to

  • Study type: Interventional · Phase 1
  • Participants enrolled: 150
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
UZ Leuven
Coordinator of this site? Confirm its status
LeuvenBelgiumCompleted

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.